Search results
Results from the WOW.Com Content Network
PRL-8-53 is a nootropic substituted phenethylamine that has been shown to act as a hypermnesic drug in humans; it was first synthesized by medical chemistry professor Nikolaus Hansl at Creighton University in the 1970s as part of his work on amino ethyl meta benzoic acid esters.
para-Bromoamphetamine (PBA), also known as 4-bromoamphetamine (4-BA), is an amphetamine derivative which acts as a serotonin-norepinephrine-dopamine releasing agent (SNDRA) and produces stimulant effects. Another related compound is para-bromomethamphetamine (PBMA) known by the codename V-111. [1]
Methyl benzoate is an organic compound. It is an ester with the chemical formula C 6 H 5 COOCH 3, sometimes abbreviated as PhCO 2 Me, where Ph and Me are phenyl and methyl, respectively. Its structure is C 6 H 5 −C(=O)−O−CH 3. It is a colorless liquid that is poorly soluble in water, but miscible with organic solvents.
Halogenation with thionyl chloride gave 4-Bromo-3,5-dimethoxybenzoyl chloride [56518-43-5] (6). Rosenmund reduction gave 4-Bromo-3,5-dimethoxybenzaldehyde [31558-40-4] (7). {Alternatively DIBAL meant that FGI from ester to aldehyde was accomplished in only 1 step}.
Ethyl ester of α-bromoisovaleric acid (ethyl 2-bromo-3-methylbutyrate) — 20 mg; Phenobarbital — 18.26 mg; Peppermint oil — 1.42 mg; Inactive ingredients: stabilizer, ethanol 96%, purified water. According to the Farmak product label, the composition of 1 tablet is as follows: [7] Ethyl ester of α-bromoisovaleric acid — 12.42 mg
4'-Bromo-4-methylaminorex (4B-MAR, 4'-Br-4-MAR) is a designer drug from the substituted aminorex family, first definitively identified in Austria in January 2022. Its pharmacological activity has not been reported, but it is believed to have stimulant effects.
4-Bromobenzaldehyde, or p-bromobenzaldehyde, is an organobromine compound with the formula BrC 6 H 4 CHO. It is one of three isomers of bromobenzaldehyde . [ 3 ] It displays reactivity characteristic of benzaldehyde and an aryl bromide .
4-Bromo-3,5-dimethoxyamphetamine is a lesser-known psychedelic drug and a substituted amphetamine. It was first synthesized by Alexander Shulgin. In his book PiHKAL, the dosage range is listed as 4–10 mg and the duration is listed as 8–12 hours. [1] It produces analgesia, numbness, and reduction of physical feeling. Very little data exists ...